Envoy Medical (COCHW) Operating Income (2021 - 2026)

Envoy Medical has disclosed Operating Income across 6 years of filings, most recently posting -$6.0 million for Q1 2026.

• Operating Income for Q1 2026 came in at -$6.0 million, down 16.68% year-over-year; the trailing twelve-month figure through Mar 2026 was -$23.1 million (down 18.7% YoY), and the FY2025 annual result was -$22.3 million, down 15.65% from the prior year.
• Operating Income came in at -$6.0 million for Q1 2026 at Envoy Medical, up from -$6.4 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$901356.0 in Q2 2022 to a low of -$6.7 million in Q4 2023.
• The 5-year median for Operating Income is -$4.9 million (2024), against an average of -$4.3 million.
• Across the five-year window, Operating Income surged 39.86% in 2022 and slumped 397.03% in 2023, its largest moves.
• Envoy Medical's Operating Income stood at -$2.9 million in 2022, then slumped by 131.35% to -$6.7 million in 2023, then soared by 32.34% to -$4.5 million in 2024, then slumped by 40.36% to -$6.4 million in 2025, then climbed by 6.67% to -$6.0 million in 2026.
• The last three Operating Income figures came in at -$6.0 million (Q1 2026), -$6.4 million (Q4 2025), and -$5.7 million (Q3 2025), per Business Quant data.